Skip to main content
. 2009 Feb 4;64A(4):492–498. doi: 10.1093/gerona/gln043

Table 3.

Multivariable Relationship Between CNS Medication Use and Recurrent Falls*

CNS Medication Use Falls (2+ vs 0–1), Crude OR (95% CI) Exact p Value Falls (2+ vs 0–1), Adjusted OR (95% CI) Exact p Value
Use of 2+ agents 2.45 (1.71–3.51) <.0001 1.95 (1.35–2.81) .0004
Use of 1 agent 1.79 (1.41–2.27) <.0001 1.55 (1.22–1.97) .0004
No use Reference Reference
Higher dose use (>3 SDD) 3.47 (2.36–5.09) <.0001 2.89 (1.96–4.25) <.0001
Moderate dose use (1–3 SDD) 2.15 (1.58–2.94) <.0001 1.80 (1.31–2.47) .0003
Lowest dose use (<1.0 SDD) 1.68 (1.12–2.49) .01 1.42 (0.95–2.15) .5971
No use Reference Reference
Long-term use 1.48 (1.24–1.77) <.0001 1.76 (1.35–2.28) <.0001
Short-term use 1.36 (1.11–1.67) <.001 1.49 (1.11–2.01) .008
No use Reference Reference

Notes CI = confidence interval; CNS = central nervous system; OR = odds ratio; SDD = summated standard daily dose.

*

Multivariable Generalized Estimating Equation analyses adjusted for sociodemographic, health behavior, health status factors, and indications for CNS medications.